FSLEX
Price
$51.65
Change
+$0.24 (+0.47%)
Updated
Sep 8 closing price
Net Assets
661.96M
RYPAX
Price
$57.59
Change
-$0.69 (-1.18%)
Updated
Sep 8 closing price
Net Assets
5.84M
Interact to see
Advertisement

FSLEX vs RYPAX

FSLEX vs RYPAX Comparison Chart in %
View a ticker or compare two or three
VS
FSLEX vs. RYPAX commentary
Sep 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLEX is a StrongBuy and RYPAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSLEX has more cash in the bank: 662M vs. RYPAX (5.84M). FSLEX pays higher dividends than RYPAX: FSLEX (0.37) vs RYPAX (0.05). FSLEX was incepted earlier than RYPAX: FSLEX (37 years) vs RYPAX (28 years). RYPAX (1.68) is less costly to investors than FSLEX (0.68). RYPAX is a more actively managed with annual turnover of: 372.00 vs. FSLEX (50.00). FSLEX has a lower initial minimum investment than RYPAX: FSLEX (0) vs RYPAX (2500). FSLEX annual gain was more profitable for investors over the last year : 15.27 vs. RYPAX (9.40). FSLEX return over 5 years is better than : 46.75 vs. RYPAX (-16.62).
FSLEXRYPAXFSLEX / RYPAX
Total Expense Ratio0.681.6342%
Annual Report Gross Expense Ratio0.681.6840%
Fund Existence37 years28 years-
Gain YTD8.8004.914179%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets662M5.84M11,330%
Annual Yield % from dividends0.370.05703%
Returns for 1 year15.279.40162%
Returns for 3 years69.3219.32359%
Returns for 5 years46.75-16.62-281%
Returns for 10 years156.9941.98374%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DWOIX20.34N/A
N/A
BNY Mellon Research Growth I
JLCFX74.98N/A
N/A
JHancock Fundamental Large Cap Core R4
VDMAX11.52N/A
N/A
Virtus KAR Developing Markets A
MNOPX34.47N/A
N/A
Morgan Stanley Inst International Opp R6
CWSRX23.24N/A
N/A
Carillon Chartwell Small Cap Growth R-6